Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot prevention study of ulipristal acetate on breast cancer risk markers
2015-001587-19Phase 2Unknown
- Sponsor
- Manchester University NHS Foundation Trust
- Start
- Jul 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of ulipristal in breast cancer, sponsored by Manchester University NHS Foundation Trust. Primary endpoint: Change in proliferation of normal breast epithelium (Ki67). Status: unknown.
02
Drugs
ulipristal
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2015-001587-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001587-19.